We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-10.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$501M
AUM Growth
+$25.6M
Cap. Flow
+$93.2M
Cap. Flow %
18.6%
Top 10 Hldgs %
66.14%
Holding
135
New
29
Increased
35
Reduced
10
Closed
61

Top Buys

Rank Stock Value
1
ICUI icon
ICU Medical
ICUI
+$5.87M
2
INSP icon
Inspire Medical Systems
INSP
+$5.07M
3
GH icon
Guardant Health
GH
+$4.07M
4
SIBN icon
SI-BONE Inc
SIBN
+$4.06M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$3.8M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.34M
2
MDT icon
Medtronic
MDT
+$7.57M
3
AZTA icon
Azenta
AZTA
+$5.7M
4
CNC icon
Centene
CNC
+$5.49M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 28.11%
2 Industrials 0.17%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
51
KALA BIO
KALA
$16.3M
$1.06M 0.21%
+86
New +$1.49M
PTLA
52
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$976K 0.19%
+50,000
New +$1.03M
PTLA
53
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$976K 0.19%
+50,000
New +$1.03M
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
$942K 0.19%
+57,131
New +$962K
VRAY
55
CALL
DELISTED
ViewRay, Inc.
VRAY
$911K 0.18%
150,000
-25,000
-14% -$187K
VNDA icon
56
PUT
Vanda Pharmaceuticals
VNDA
$298M
$899K 0.18%
+34,400
New +$809K
MASI
57
DELISTED
Masimo
MASI
$836K 0.17%
+7,783
New +$868K
BSX icon
58
Boston Scientific
BSX
$74.2B
$814K 0.16%
23,035
-229,890
-91% -$8.34M
RIGL icon
59
Rigel Pharmaceuticals
RIGL
$785M
$764K 0.15%
33,206
+2,957
+10% +$83.4K
OFIX icon
60
Orthofix Medical
OFIX
$420M
$669K 0.13%
12,738
-78,320
-86% -$4.45M
ACET
61
DELISTED
Aceto Corp
ACET
$591K 0.12%
704,034
+492,410
+233% +$882K
INGN icon
62
Inogen
INGN
$157M
$580K 0.12%
+4,669
New +$769K
VRCA icon
63
Verrica Pharmaceuticals
VRCA
$89.7M
$521K 0.1%
6,392
+4,392
+220% +$533K
SNDX icon
64
CALL
Syndax Pharmaceuticals
SNDX
$1.81B
$493K 0.1%
110,700
+10,700
+11% +$58.7K
CPRX
65
DELISTED
Catalyst Pharmaceutical
CPRX
$346K 0.07%
180,198
-22,291
-11% -$63.8K
ITCI
66
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$316K 0.06%
27,700
+2,700
+11% +$43.6K
CARM
67
DELISTED
Carisma Therapeutics
CARM
$284K 0.06%
+10,000
New +$319K
RCM
68
DELISTED
R1 RCM Inc. Common Stock
RCM
$281K 0.06%
35,283
-191,826
-84% -$1.66M
CSII
69
DELISTED
Cardiovascular Systems, Inc.
CSII
$227K 0.05%
+7,952
New +$253K
AXSM icon
70
CALL
Axsome Therapeutics
AXSM
$11.1B
$209K 0.04%
+74,000
New +$243K
ARQL
71
DELISTED
Arqule Inc
ARQL
$199K 0.04%
+71,968
New +$275K
KOD icon
72
Kodiak Sciences
KOD
$2.64B
$173K 0.03%
+24,319
New +$215K
GRCE
73
Grace Therapeutics
GRCE
$44.6M
$157K 0.03%
+3,922
New +$171K
ADMA icon
74
ADMA Biologics
ADMA
$2.22B
$89K 0.02%
37,170
-534,147
-93% -$2.65M
ALKS icon
75
CALL
Alkermes
ALKS
$8.26B
– –
-50,000
Closed -$2.12M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Pura Vida Investments held 135 positions worth $501M, up 5.4% from $475M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Pura Vida Investments deployed $93.2M of net new capital in Q4 2018, opening 29 new positions and adding to 35 existing holdings. Its largest new stake was Guardant Health: 110,363 shares worth $4.15M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 35% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Boston Scientific, an estimated $8.34M trimmed.

  • Pura Vida Investments's largest Q4 2018 buy was Guardant Health: 110,363 shares worth $4.15M.
  • Pura Vida Investments added most to ICU Medical in Q4 2018, an estimated $5.87M increase.
  • Pura Vida Investments's biggest Q4 2018 reduction was Boston Scientific, cutting an estimated $8.34M.
  • Pura Vida Investments fully exited Medtronic in Q4 2018, selling an estimated $7.57M.
  • Pura Vida Investments's ten largest holdings make up 66% of its $501M portfolio in Q4 2018.
  • Pura Vida Investments opened 29 new positions and closed 61 in Q4 2018.
  • Pura Vida Investments's portfolio value rose 5.4% quarter-over-quarter to $501M.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.